PEDIATRICS Vol. 85 No. 6 June 1990, pp. 1086-1091
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brent, D. A.
Right arrow Articles by Allan, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brent, D. A.
Right arrow Articles by Allan, M. J.

Phenobarbital Treatment and Major Depressive Disorder in Children With Epilepsy: A Naturalistic Follow-up

David A. Brent MD1, Patricia K. Crumrine MD1, Rajiv Varma MD1, Robert V. Brown 1, and Marjorie J. Allan 1

1 From the Western Psychiatric Institute and Clinic, Children's Hospital of Pittsburgh, and Mercy Hospital, Pittsburgh, Pennsylvania

Of an original cohort of 39 epileptic patients, 28 were observed for a median of 26.5 months after an initial psychiatric interview. As had been noted in the original cohort, treatment with phenobarbital, as compared with treatment with carbamazepine or no anticonvulsant, was associated with higher rates of depression (38% vs 0%, P = .04). Depression associated with phenobarbital treatment at intake did not remit spontaneously on follow-up as long as phenobarbital use continued. Those patients treated with phenobarbital who were previously depressed and whose medication was changed to either carbamazepine or no medication showed nonsignificant trends toward declines in both the frequency and severity of depressive symptoms. These results provide further evidence that treatment with phenobarbital increases the risk for depression in epileptic patients and should be avoided when clinically feasible, particularly in patients with a personal or family history of affective disorder. Epileptic patients who receive phenobarbital because of clinical considerations should be monitored closely for symptoms of an affective disorder, and if depression is detected, a change to an alternative anticonvulsant may result in amelioration of depressive symptomatology.

Key Words: epilepsy • phenobarbital • carbamazepine • depression

Submitted on April 19, 1989
Accepted on July 26, 1989




This article has been cited by other articles:


Home page
 NeurologyHome page
R. Sankar
Initial treatment of epilepsy with antiepileptic drugs: Pediatric issues
Neurology, November 23, 2004; 63(10_suppl_4): S30 - S39.
[Abstract] [Full Text]

Home page
 J Child NeurolHome page
T. A. Glauser
Behavioral and Psychiatric Adverse Events Associated With Antiepileptic Drugs Commonly Used in Pediatric Patients
J Child Neurol, August 1, 2004; 19(1_suppl): S25 - S38.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
J. Goldstein, S. Plioplys, F. Zelko, S. Mass, C. Corns, R. Blaufuss, and D. Nordli
Multidisciplinary Approach to Childhood Epilepsy: Exploring the Scientific Rationale and Practical Aspects of Implementation
J Child Neurol, May 1, 2004; 19(5): 362 - 378.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
T. A. Glauser
Behavioral and Psychiatric Adverse Events Associated With Antiepileptic Drugs Commonly Used in Pediatric Patients
J Child Neurol, January 1, 2004; 19(1_suppl): S25 - S38.
[Abstract] [PDF]

Home page
 PsychosomaticsHome page
P. Burke and M. Elliott
Depression in Pediatric Chronic Illness: A Diathesis-Stress Model
Psychosomatics, February 1, 1999; 40(1): 5 - 17.
[Abstract] [Full Text]